Physiologic characterization of type 2 diabetes-related loci

Current Diabetes Reports

Volumn 10, Issue 6, 2010, Pages 485-497

  Grarup, Niels ^a   Sparsø, Thomas ^a   Hansen, Torben ^b  

^a HAGEDORN RESEARCH INSTITUTE   (Denmark)

^b NONE

Author keywords

cell function; Genetic epidemiology; Glycemia; Insulin sensitivity; Physiology; Type 2 diabetes

Indexed keywords

GLUCOKINASE; GLUCOKINASE REGULATOR PROTEIN; INSULIN RECEPTOR SUBSTRATE 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN FTO; REGULATOR PROTEIN; SOMATOMEDIN C; SULFONYLUREA RECEPTOR 1; TRANSCRIPTION FACTOR 7 LIKE 2; UNCLASSIFIED DRUG;

GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC VARIABILITY; GLUCOSE HOMEOSTASIS; HUMAN; INSULIN RELEASE; INSULIN SENSITIVITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PANCREAS ISLET BETA CELL; PATHOGENESIS; QUANTITATIVE TRAIT; QUANTITATIVE TRAIT LOCUS; REVIEW;

ANIMALS; DIABETES MELLITUS, TYPE 2; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; INSULIN RESISTANCE; INSULIN-SECRETING CELLS;

EID: 77958504442     PISSN: 15344827     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11892-010-0154-y     Document Type: Review

References (84)

1. P Zimmet KG Alberti J Shaw 2001 Global and societal implications of the diabetes epidemic Nature 414 782 787 1:CAS:528:DC%2BD38Xhtlymtg%3D%3D 10.1038/414782a 11742409 (Pubitemid 34000780)
2. Köbberling J, Tillil H (1982) Empirical risk figures for first degree relatives of non-insulin dependent diabetics. In The Genetics of Diabetes Mellitus. Edited by Köbberling J, Tattersall R. London: Academic Press, pp 201-209.
3. V Lyssenko P Almgren D Anevski, et al. 2005 Predictors of and longitudinal changes in insulin sensitivity and secretion preceding onset of type 2 diabetes Diabetes 54 166 174 1:CAS:528:DC%2BD2MXhtVWisr4%3D 10.2337/diabetes.54.1.166 15616025 (Pubitemid 40105109)
4. A Vaag P Poulsen 2007 Twins in metabolic and diabetes research: what do they tell us? Curr Opin Clin Nutr Metab Care 10 591 596 1:CAS:528: DC%2BD2sXhtFWitbfE 10.1097/MCO.0b013e3282ab9ea6 17693742 (Pubitemid 47254720)
5. AH Barnett C Eff RD Leslie DA Pyke 1981 Diabetes in identical twins. A study of 200 pairs Diabetologia 20 87 93 1:STN:280:DyaL3M7jvFersQ%3D%3D 10.1007/BF00262007 7193616 (Pubitemid 11138466)
6. B Newman JV Selby MC King, et al. 1987 Concordance for type 2 (non-insulin-dependent) diabetes mellitus in male twins Diabetologia 30 763 768 1:STN:280:DyaL1c7ht1GmsA%3D%3D 10.1007/BF00275741 3428496
7. J Kaprio J Tuomilehto M Koskenvuo, et al. 1992 Concordance for type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus in a population-based cohort of twins in Finland Diabetologia 35 1060 1067 1:STN:280:DyaK3s7hsVCqsA%3D%3D 10.1007/BF02221682 1473616
8. P Poulsen KO Kyvik A Vaag H Beck-Nielsen 1999 Heritability of type II (non-insulin-dependent) diabetes mellitus and abnormal glucose tolerance-a population-based twin study Diabetologia 42 139 145 1:CAS:528:DyaK1MXhtFajsbk%3D 10.1007/s001250051131 10064092 (Pubitemid 29064234)
9. RM Watanabe T Valle ER Hauser, et al. 1999 Familiality of quantitative metabolic traits in Finnish families with non-insulin-dependent diabetes mellitus. Finland-United States Investigation of NIDDM Genetics (FUSION) Study investigators Hum Hered 49 159 168 1:STN:280:DyaK1M3psVOgtw%3D%3D 10.1159/000022865 10364681 (Pubitemid 29261381)
10. M Lehtovirta J Kaprio C Forsblom, et al. 2000 Insulin sensitivity and insulin secretion in monozygotic and dizygotic twins Diabetologia 43 285 293 1:CAS:528:DC%2BD3cXhsFyltbY%3D 10.1007/s001250050046 10768089
11. M Lehtovirta J Kaprio L Groop, et al. 2005 Heritability of model-derived parameters of beta cell secretion during intravenous and oral glucose tolerance tests: a study of twins Diabetologia 48 1604 1613 1:STN:280: DC%2BD2MvivFGgsw%3D%3D 10.1007/s00125-005-1815-2 15977011 (Pubitemid 41175514)
12. AM Simonis-Bik EM Eekhoff MH de Moor, et al. 2009 Genetic influences on the insulin response of the beta cell to different secretagogues Diabetologia 52 2570 2577 1:CAS:528:DC%2BD1MXhsVWls7jO 10.1007/s00125-009-1532-3 19802603
13. P Poulsen K Levin I Petersen, et al. 2005 Heritability of insulin secretion, peripheral and hepatic insulin action, and intracellular glucose partitioning in young and old Danish twins Diabetes 54 275 283 1:CAS:528:DC%2BD2MXhtVWis7o%3D 10.2337/diabetes.54.1.275 15616039 (Pubitemid 40105123)
14. MI McCarthy E Zeggini 2009 Genome-wide association studies in type 2 diabetes Curr Diab Rep 9 164 171 1:CAS:528:DC%2BC3cXhtFersrrI 10.1007/s11892-009-0027-4 19323962
15. • Saxena R, Hivert MF, Langenberg C, et al.: Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge. Nat Genet 2010, 42:142-148. Discovery of variation in GIPR associated with glucose traits and impaired incretin effect and β-cell function. The paper combines novel discovery with human physiology data and simple functional studies.
16. J Dupuis C Langenberg I Prokopenko, et al. 2010 New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk Nat Genet 42 105 116 1:CAS:528:DC%2BC3cXntVCqsw%3D%3D 10.1038/ng.520 20081858
17. JC Florez KA Jablonski N Bayley, et al. 2006 TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program N Engl J Med 355 241 250 1:CAS:528:DC%2BD28XntVWktrw%3D 10.1056/NEJMoa062418 16855264 (Pubitemid 44079339)
18. JC Florez KA Jablonski J McAteer, et al. 2008 Testing of diabetes-associated WFS1 polymorphisms in the Diabetes Prevention Program Diabetologia 51 451 457 1:STN:280:DC%2BD1c3nsFCluw%3D%3D 10.1007/s00125-007- 0891-x 18060660
19. T Sparsø G Andersen A Albrechtsen, et al. 2008 Impact of polymorphisms in WFS1 on prediabetic phenotypes in a population-based sample of middle-aged people with normal and abnormal glucose regulation Diabetologia 51 1646 1652 10.1007/s00125-008-1064-2 18568334
20. EM Nielsen L Hansen B Carstensen, et al. 2003 The E23K variant of Kir6.2 associates with impaired post-OGTT serum insulin response and increased risk of type 2 diabetes Diabetes 52 573 577 1:CAS:528:DC%2BD3sXhtFansbc%3D 10.2337/diabetes.52.2.573 12540638 (Pubitemid 36173219)
21. V Steinthorsdottir G Thorleifsson I Reynisdottir, et al. 2007 A variant in CDKAL1 influences insulin response and risk of type 2 diabetes Nat Genet 39 770 775 1:CAS:528:DC%2BD2sXlvVSgtL4%3D 10.1038/ng2043 17460697 (Pubitemid 46848592)
22. • Grarup N, Rose CS, Andersson EA, et al.: Studies of association of variants near the HHEX, CDKN2A/B, and IGF2BP2 genes with type 2 diabetes and impaired insulin release in 10,705 Danish subjects: validation and extension of genome-wide association studies. Diabetes 2007, 56:3105-3111. One of the first studies to show that novel type 2 diabetes risk genes inflict a decreased β-cell function.
23. • Pascoe L, Tura A, Patel SK, et al.: Common variants of the novel type 2 diabetes genes CDKAL1 and HHEX/IDE are associated with decreased pancreatic beta-cell function. Diabetes 2007, 56:3101-3104. One of the first studies to show that novel type 2 diabetes risk genes inflict a decreased β-cell function.
24. • Staiger H, Machicao F, Stefan N, et al.: Polymorphisms within novel risk loci for type 2 diabetes determine beta-cell function. PLoS One 2007, 2:e832. One of the first studies to show that novel type 2 diabetes risk genes inflict a decreased β-cell function.
25. TW Boesgaard J Zilinskaite M Vänttinen, et al. 2008 The common SLC30A8 Arg325Trp variant is associated with reduced first-phase insulin release in 846 non-diabetic offspring of type 2 diabetes patients-the EUGENE2 study Diabetologia 51 816 820 1:CAS:528:DC%2BD1cXkt1yjs78%3D 10.1007/s00125-008-0955-6 18324385
26. N Grarup G Andersen NT Krarup, et al. 2008 Association testing of novel type 2 diabetes risk alleles in the JAZF1, CDC123/CAMK1D, TSPAN8, THADA, ADAMTS9, and NOTCH2 loci with insulin release, insulin sensitivity, and obesity in a population-based sample of 4,516 glucose-tolerant middle-aged Danes Diabetes 57 2534 2540 1:CAS:528:DC%2BD1cXhtFSrtrbO 10.2337/db08-0436 18567820
27. •• Lyssenko V, Nagorny CL, Erdos MR, et al.: Common variant in MTNR1B associated with increased risk of type 2 diabetes and impaired early insulin secretion. Nat Genet 2009, 41:82-88. Discovery of variation in MTNR1B associated with fasting glucose and impaired β-cell function. The paper combines novel discovery with human physiology data and expression studies.
28. K Yasuda K Miyake Y Horikawa, et al. 2008 Variants in KCNQ1 are associated with susceptibility to type 2 diabetes mellitus Nat Genet 40 1092 1097 1:CAS:528:DC%2BD1cXhtVGgt77M 10.1038/ng.207 18711367
29. H Staiger F Machicao SA Schafer, et al. 2008 Polymorphisms within the novel type 2 diabetes risk locus MTNR1B determine beta-cell function PLoS One 3 e3962 10.1371/journal.pone.0003962 19088850
30. V Lyssenko A Jonsson P Almgren, et al. 2008 Clinical risk factors, DNA variants, and the development of type 2 diabetes N Engl J Med 359 2220 2232 1:CAS:528:DC%2BD1cXhtl2gurnF 10.1056/NEJMoa0801869 19020324
31. JC Florez N Burtt PI de Bakker, et al. 2004 Haplotype structure and genotype-phenotype correlations of the sulfonylurea receptor and the islet ATP-sensitive potassium channel gene region Diabetes 53 1360 1368 1:CAS:528:DC%2BD2cXjslKhs78%3D 10.2337/diabetes.53.5.1360 15111507 (Pubitemid 38569024)
32. H Staiger F Machicao K Kantartzis, et al. 2008 Novel meta-analysis- derived type 2 diabetes risk loci do not determine prediabetic phenotypes PLoS One 3 e3019 10.1371/journal.pone.0003019 18714373
33. D Schleinitz A Tonjes Y Bottcher, et al. 2010 Lack of significant effects of the type 2 diabetes susceptibility loci JAZF1, CDC123/CAMK1D, NOTCH2, ADAMTS9, THADA, and TSPAN8/LGR5 on diabetes and quantitative metabolic traits Horm Metab Res 42 14 22 1:CAS:528:DC%2BC3cXht1eksL0%3D 10.1055/s-0029-1233480 19670153
34. A Stancáková T Kuulasmaa J Paananen, et al. 2009 Association of 18 confirmed susceptibility loci for type 2 diabetes with indices of insulin release, proinsulin conversion, and insulin sensitivity in 5, 327 nondiabetic Finnish men Diabetes 58 2129 2136 10.2337/db09-0117 19502414
35. MJ Groenewoud JM Dekker A Fritsche, et al. 2008 Variants of CDKAL1 and IGF2BP2 affect first-phase insulin secretion during hyperglycaemic clamps Diabetologia 51 1659 1663 1:CAS:528:DC%2BD1cXpsVGitb4%3D 10.1007/s00125-008- 1083-z 18618095
36. H Staiger A Stancakova J Zilinskaite, et al. 2008 A candidate type 2 diabetes polymorphism near the HHEX locus affects acute glucose-stimulated insulin release in European populations: results from the EUGENE2 study Diabetes 57 514 517 1:CAS:528:DC%2BD1cXhvVOktLc%3D 10.2337/db07-1254 18039816
37. ND Palmer MO Goodarzi CD Langefeld, et al. 2008 Quantitative trait analysis of type 2 diabetes susceptibility loci identified from whole genome association studies in the Insulin Resistance Atherosclerosis Family Study Diabetes 57 1093 1100 1:CAS:528:DC%2BD1cXksVGrsr8%3D 10.2337/db07-1169 18252897
38. F Chimienti S Devergnas F Pattou, et al. 2006 In vivo expression and functional characterization of the zinc transporter ZnT8 in glucose-induced insulin secretion J Cell Sci 119 4199 4206 1:CAS:528:DC%2BD28Xht1GksrbP 10.1242/jcs.03164 16984975 (Pubitemid 44774026)
39. K Kirchhoff F Machicao A Haupt, et al. 2008 Polymorphisms in the TCF7L2, CDKAL1 and SLC30A8 genes are associated with impaired proinsulin conversion Diabetologia 51 597 601 1:CAS:528:DC%2BD1cXjsFGiu7o%3D 10.1007/s00125-008-0926-y 18264689
40. •• Ingelsson E, Langenberg C, Hivert MF, et al.: Detailed physiologic characterization reveals diverse mechanisms for novel genetic loci regulating glucose and insulin metabolism in humans. Diabetes 2010, 59:1266-1275. The first study to perform a large-scale meta-analysis of OGTT data for known diabetes-associated loci to obtain statistical power to detect small effects on intermediary quantitative trait.
41. M Slucca JS Harmon EA Oseid, et al. 2010 ATP-sensitive K+ channel mediates the zinc switch-off signal for glucagon response during glucose deprivation Diabetes 59 128 134 1:CAS:528:DC%2BC3cXmtVKnsA%3D%3D 10.2337/db09-1098 19808893
42. DT Villareal H Robertson GI Bell, et al. 2010 TCF7L2 variant rs7903146 affects the risk of type 2 diabetes by modulating incretin action Diabetes 59 479 485 1:CAS:528:DC%2BC3cXhvVyru7Y%3D 10.2337/db09-1169 19934000
43. • Lyssenko V, Lupi R, Marchetti P, et al.: Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes. J Clin Invest 2007, 117:2155-2163. A detailed and large study showing that a risk variant in TCF7L2 has an impact on the incretion effect and TCF7L2 expression in human pancreatic islets.
44. K Pilgaard CB Jensen JH Schou, et al. 2009 The T allele of rs7903146 TCF7L2 is associated with impaired insulinotropic action of incretin hormones, reduced 24 h profiles of plasma insulin and glucagon, and increased hepatic glucose production in young healthy men Diabetologia 52 1298 1307 1:CAS:528:DC%2BD1MXms1yhs70%3D 10.1007/s00125-009-1307-x 19288077
45. SA Schafer O Tschritter F Machicao, et al. 2007 Impaired glucagon-like peptide-1-induced insulin secretion in carriers of transcription factor 7-like 2 (TCF7L2) gene polymorphisms Diabetologia 50 2443 2450 1:STN:280: DC%2BD2snlslOhtA%3D%3D 10.1007/s00125-007-0753-6 17661009 (Pubitemid 350060632)
46. SA Schafer K Mussig H Staiger, et al. 2009 A common genetic variant in WFS1 determines impaired glucagon-like peptide-1-induced insulin secretion Diabetologia 52 1075 1082 1:STN:280:DC%2BD1Mzht1Wguw%3D%3D 10.1007/s00125-009- 1344-5 19330314
47. K Mussig H Staiger F Machicao, et al. 2009 Association of type 2 diabetes candidate polymorphisms in KCNQ1 with incretin and insulin secretion Diabetes 58 1715 1720 10.2337/db08-1589 19366866
48. • Simonis-Bik AM, Nijpels G, van Haeften TW, et al.: Gene variants in the novel type 2 diabetes loci CDC123/CAMK1D, THADA, ADAMTS9, BCL11A, and MTNR1B affect different aspects of pancreatic beta-cell function. Diabetes 2010, 59:293-301. A detailed study of many type 2 diabetes risk variants by a hyperglycemic clamp combined with GLP-1 and arginine stimulation.
49. BF Voight LJ Scott V Steinthorsdottir, et al. 2010 Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis Nat Genet 42 579 589 1:CAS:528:DC%2BC3cXnvFykt70%3D 10.1038/ng.609 20581827
50. SS Deeb L Fajas M Nemoto, et al. 1998 A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity Nat Genet 20 284 287 1:CAS:528: DyaK1cXntFOhsL8%3D 10.1038/3099 9806549 (Pubitemid 28507675)
51. J Ek G Andersen SA Urhammer, et al. 2001 Studies of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor g2 (PPARg2) gene in relation to insulin sensitivity among glucose tolerant Caucasians Diabetologia 44 1170 1176 1:CAS:528:DC%2BD3MXmtlWlt78%3D 10.1007/s001250100629 11596673 (Pubitemid 32835510)
52. •• Rung J, Cauchi S, Albrechtsen A, et al.: Genetic variant near IRS1 is associated with type 2 diabetes, insulin resistance and hyperinsulinemia. Nat Genet 2009, 41:1110-1115. The first finding of a variant near IRS1 associated with type 2 diabetes, insulin resistance, IRS1 expression, and insulin signaling. Combined association analysis and functional studies.
53. TW Boesgaard AP Gjesing N Grarup, et al. 2009 Variant near ADAMTS9 known to associate with type 2 diabetes is related to insulin resistance in offspring of type 2 diabetes patients-EUGENE2 study PLoS One 4 e7236 10.1371/journal.pone. 0007236 19789630
54. L Qi MC Cornelis P Kraft, et al. 2010 Genetic variants at 2q24 are associated with susceptibility to type 2 diabetes Hum Mol Genet 19 2706 2715 1:CAS:528:DC%2BC3cXntlCquro%3D 10.1093/hmg/ddq156 20418489
55. Diabetes Genetics Initiative of Broad Institute of Harvard and MIT, Lund University, and Novartis Institutes of BioMedical Research R Saxena BF Voight, et al. 2007 Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels Science 316 1331 1336 1:CAS:528:DC%2BD2sXmtVyitrk%3D 10.1126/science.1142358 17463246 (Pubitemid 46871653)
56. M Orho-Melander O Melander C Guiducci, et al. 2008 Common missense variant in the glucokinase regulatory protein gene is associated with increased plasma triglyceride and C-reactive protein but lower fasting glucose concentrations Diabetes 57 3112 3121 1:CAS:528:DC%2BD1MXhsleis7Y%3D 10.2337/db08-0516 18678614
57. T Sparsø G Andersen T Nielsen, et al. 2008 The GCKR rs780094 polymorphism is associated with elevated fasting serum triacylglycerol, reduced fasting and OGTT-related insulinaemia, and reduced risk of type 2 diabetes Diabetologia 51 70 75 10.1007/s00125-007-0865-z 18008060 (Pubitemid 50003447)
58. MN Weedon TM Frayling B Shields, et al. 2005 Genetic regulation of birth weight and fasting glucose by a common polymorphism in the islet cell promoter of the glucokinase gene Diabetes 54 576 581 1:CAS:528:DC%2BD2MXhsVCrtrY%3D 10.2337/diabetes.54.2.576 15677518
59. CS Rose J Ek SA Urhammer, et al. 2005 A -30G∈>∈A polymorphism of the beta-cell-specific glucokinase promoter associates with hyperglycemia in the general population of whites Diabetes 54 3026 3031 1:CAS:528:DC%2BD2MXhtV2rs7zE 10.2337/diabetes.54.10.3026 16186409 (Pubitemid 41401103)
60. WM Chen MR Erdos AU Jackson, et al. 2008 Variations in the G6PC2/ABCB11 genomic region are associated with fasting glucose levels J Clin Invest 118 2620 2628 1:CAS:528:DC%2BD1cXot1Onu74%3D 18521185
61. N Bouatia-Naji G Rocheleau L Van-Lommel, et al. 2008 A polymorphism within the G6PC2 gene is associated with fasting plasma glucose levels Science 320 1085 1088 1:CAS:528:DC%2BD1cXmtVKnsLc%3D 10.1126/science.1156849 18451265 (Pubitemid 351929551)
62. N Bouatia-Naji A Bonnefond C Cavalcanti-Proença, et al. 2009 A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk Nat Genet 41 89 94 1:CAS:528:DC%2BD1cXhsVKlt7zP 10.1038/ng.277 19060909
63. I Prokopenko C Langenberg JC Florez, et al. 2009 Variants in MTNR1B influence fasting glucose levels Nat Genet 41 77 81 1:CAS:528:DC%2BD1cXhsVKlt7vM 10.1038/ng.290 19060907
64. T Sparsø A Bonnefond E Andersson, et al. 2009 G-allele of intronic rs10830963 in MTNR1B confers increased risk of impaired fasting glycemia and type 2 diabetes through an impaired glucose-stimulated insulin release: studies involving 19, 605 Europeans Diabetes 58 1450 1456 10.2337/db08-1660 19324940
65. CS Rose N Grarup NT Krarup, et al. 2009 A variant in the G6PC2/ABCB11 locus is associated with increased fasting plasma glucose, increased basal hepatic glucose production and increased insulin release after oral and intravenous glucose loads Diabetologia 52 2122 2129 1:CAS:528:DC%2BD1MXhtVygtLnI 10.1007/s00125-009-1463-z 19669124
66. TW Boesgaard N Grarup T Jørgensen, et al. 2010 Variants at DGKB/TMEM195, ADRA2A, GLIS3 and C2CD4B loci are associated with reduced glucose-stimulated beta cell function in middle-aged Danish people Diabetologia 53 1647 1655 1:CAS:528:DC%2BC3cXotVKgs70%3D 10.1007/s00125-010-1753-5 20419449
67. EA Andersson K Pilgaard C Pisinger, et al. 2010 Type 2 diabetes risk alleles near ADCY5, CDKAL1 and HHEX-IDE are associated with reduced birthweight Diabetologia 53 1908 1916 1:CAS:528:DC%2BC3cXpsV2ltbk%3D 10.1007/s00125-010- 1790-0 20490451
68. RM Freathy DO Mook-Kanamori U Sovio, et al. 2010 Variants in ADCY5 and near CCNL1 are associated with fetal growth and birth weight Nat Genet 42 430 435 1:CAS:528:DC%2BC3cXktlSgu7k%3D 10.1038/ng.567 20372150
69. TM Frayling NJ Timpson MN Weedon, et al. 2007 A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity Science 316 889 894 1:CAS:528:DC%2BD2sXltVentL0%3D 10.1126/science. 1141634 17434869 (Pubitemid 46764279)
70. CH Andreasen KL Stender-Petersen MS Mogensen, et al. 2008 Low physical activity accentuates the effect of the FTO rs9939609 polymorphism on body fat accumulation Diabetes 57 95 101 1:CAS:528:DC%2BD1cXmt1WrsQ%3D%3D 10.2337/db07-0910 17942823
71. R Do SD Bailey K Desbiens, et al. 2008 Genetic variants of FTO influence adiposity, insulin sensitivity, leptin levels, and resting metabolic rate in the Quebec Family Study Diabetes 57 1147 1150 1:CAS:528:DC%2BD1cXksVGrs74%3D 10.2337/db07-1267 18316358
72. RM Freathy NJ Timpson DA Lawlor, et al. 2008 Common variation in the FTO gene alters diabetes-related metabolic traits to the extent expected given its effect on BMI Diabetes 57 1419 1426 1:CAS:528:DC%2BD1cXlvVKjur0%3D 10.2337/db07-1466 18346983
73. L Pascoe TM Frayling MN Weedon, et al. 2008 Beta cell glucose sensitivity is decreased by 39% in non-diabetic individuals carrying multiple diabetes-risk alleles compared with those with no risk alleles Diabetologia 51 1989 1992 1:CAS:528:DC%2BD1cXht1amsrjO 10.1007/s00125-008-1124-7 18719881
74. A Haupt H Staiger SA Schafer, et al. 2009 The risk allele load accelerates the age-dependent decline in beta cell function Diabetologia 52 457 462 1:STN:280:DC%2BD1M7hs12nsg%3D%3D 10.1007/s00125-008-1250-2 19172244
75. NL Beer ND Tribble LJ McCulloch, et al. 2009 The P446L variant in GCKR associated with fasting plasma glucose and triglyceride levels exerts its effect through increased glucokinase activity in liver Hum Mol Genet 18 4081 4088 1:CAS:528:DC%2BD1MXht1CrtrvJ 10.1093/hmg/ddp357 19643913
76. TJ Nicolson EA Bellomo N Wijesekara, et al. 2009 Insulin storage and glucose homeostasis in mice null for the granule zinc transporter ZnT8 and studies of the type 2 diabetes-associated variants Diabetes 58 2070 2083 1:CAS:528:DC%2BD1MXhtFChsbbO 10.2337/db09-0551 19542200
77. KS Hamming D Soliman LC Matemisz, et al. 2009 Coexpression of the type 2 diabetes susceptibility gene variants KCNJ11 E23K and ABCC8 S1369A alter the ATP and sulfonylurea sensitivities of the ATP-sensitive K(+) channel Diabetes 58 2419 2424 1:CAS:528:DC%2BD1MXht1yrsrzM 10.2337/db09-0143 19587354
78. GV Kryukov LA Pennacchio SR Sunyaev 2007 Most rare missense alleles are deleterious in humans: implications for complex disease and association studies Am J Hum Genet 80 727 739 1:CAS:528:DC%2BD2sXktVOisrc%3D 10.1086/513473 17357078 (Pubitemid 46564409)
79. O Tschritter M Stumvoll F Machicao, et al. 2002 The prevalent Glu23Lys polymorphism in the potassium inward rectifier 6.2 (KIR6.2) gene is associated with impaired glucagon suppression in response to hyperglycemia Diabetes 51 2854 2860 1:CAS:528:DC%2BD38Xmsleru7Y%3D 10.2337/diabetes.51.9.2854 12196481
80. RJ Loos PW Franks RW Francis, et al. 2007 TCF7L2 polymorphisms modulate proinsulin levels and beta-cell function in a British Europid population Diabetes 56 1943 1947 1:CAS:528:DC%2BD2sXnvVWisrc%3D 10.2337/db07-0055 17416797 (Pubitemid 47025464)
81. R Saxena L Gianniny NP Burtt, et al. 2006 Common single nucleotide polymorphisms in TCF7L2 are reproducibly associated with type 2 diabetes and reduce the insulin response to glucose in nondiabetic individuals Diabetes 55 2890 2895 1:CAS:528:DC%2BD28XhtVGls77M 10.2337/db06-0381 17003358 (Pubitemid 44923692)
82. RM Freathy AJ Bennett SM Ring, et al. 2009 Type 2 diabetes risk alleles are associated with reduced size at birth Diabetes 58 1428 1433 1:CAS:528:DC%2BD1MXntFanu7o%3D 10.2337/db08-1739 19228808
83. A Stancakova J Pihlajamaki J Kuusisto, et al. 2008 Single-nucleotide polymorphism rs7754840 of CDKAL1 is associated with impaired insulin secretion in nondiabetic offspring of type 2 diabetic subjects and in a large sample of men with normal glucose tolerance J Clin Endocrinol Metab 93 1924 1930 1:CAS:528:DC%2BD1cXlvFWgtrs%3D 10.1210/jc.2007-2218 18285412 (Pubitemid 351656539)
84. J Zhao M Li JP Bradfield, et al. 2009 Examination of type 2 diabetes loci implicates CDKAL1 as a birth weight gene Diabetes 58 2414 2418 1:CAS:528:DC%2BD1MXht1yrsr%2FF 10.2337/db09-0506 19592620